Download this datacard
Overview
Lobbying Costs
None declared
Financial year: Jan 2017 - Dec 2017
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Irish Pharmaceutical Healthcare Association (IPHA)
EU Transparency Register
701937518594-20 First registered on 31 Aug 2015
Goals / Remit
The Irish Pharmaceutical Healthcare Association (IPHA) represents the international research based pharmaceutical industry in Ireland. Our members include both manufacturers of prescription medicines and non-prescription or consumer health care medicines.
The mission of IPHA is to create a favourable economic, regulatory and political environment, which will enable the research-based pharmaceutical industry in Ireland to meet the growing healthcare needs and expectations of patients.
It aims also to develop an appreciation of the value of medicines, in particular innovative medicines, to healthcare and society as a whole thereby ensuring patients' continued, timely access to the full range of available medicines, regardless of their ability to pay.Main EU files targeted
We track all EU polices of relevance to our business in the areas of regulation, access and pricing of innovative medicines.
Address
Head Office
Wilton Park House
Wilton Place
Dublin 2
IRELAND -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Oliver O'Connor (Chief Executive Officer)
Person with legal responsibility
Mr Oliver O'Connor (Chief Executive Officer)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade and business associations
-
Networking
Affiliation
We are members of EFPIA and AESGP
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2017 - Dec 2017
Lobbying costs for closed financial year
None declared
Other financial info
An entry of 000 has been made as their were no specific activities relevant to the register during this period.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
We are active in communicating the industry's position on the proposed EC SPC manufacturing waiver. As members of IMVO, we are preparing for the implementation of the Falsified Medicines Directive.
Other activities
None declared
Meetings
Meetings
None declared